We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRIN:XETRUniCredit S.p.A. Analysis

Data as of 2026-03-15 - not real-time

R$93.84

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Carter's shares are trading at a level that aligns with the 20‑day moving average and sits just above a clear support zone, suggesting a price floor that could hold under short‑term pressure. The broader trend remains bullish as the medium‑term average sits above the long‑term average, while the RSI indicates the stock is not yet overbought and still has upside potential. However, the MACD histogram is in negative territory and the recent decline in volume points to weakening momentum that could limit immediate gains. Market sentiment is currently in a greed phase, which may provide additional buying pressure if confidence persists.
Fundamentally, the company delivers steady revenue growth and healthy gross margins for a consumer cyclical player. Dividend yield remains attractive with a payout ratio well below the threshold that would jeopardize sustainability, and cash generation comfortably exceeds debt obligations. Valuation multiples are on the low side relative to peers, implying the stock is priced below its intrinsic worth and offering a margin of safety for long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price testing a well‑defined support level
  • bearish MACD histogram signaling near‑term downside pressure
  • declining volume reducing short‑term liquidity

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • bullish alignment of short‑, medium‑ and long‑term moving averages
  • RSI indicating room for further upside
  • valuation metrics suggesting a discount to intrinsic value

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend backed by solid cash flow
  • low leverage relative to cash reserves
  • steady growth prospects in the childrenswear segment

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin3.17%
P/E Ratio14.2
ROE10.32%
ROA3.60%
Debt/Equity131.03
P/B Ratio0.7
Op. Cash FlowR$122.3M
Free Cash FlowR$51.2M

Technical Analysis

TrendBullish
RSI39.3
SupportR$93.84
ResistanceR$103.40
MA 20R$99.42
MA 50R$91.91
MA 200R$84.33
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$3.17
GradeUndervalued
TypeBlend
Dividend Yield1.92%

Risk Assessment

Beta0.39
Volatility47.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.